Forte Biosciences (FBRX) News Today → Urgent Nvidia Warning (From Altimetry) (Ad) Free FBRX Stock Alerts $0.60 -0.03 (-4.60%) (As of 05/17/2024 08:53 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 18 at 5:02 AM | americanbankingnews.comFY2024 EPS Estimates for Forte Biosciences, Inc. (NASDAQ:FBRX) Reduced by Chardan CapitalMay 17 at 4:05 PM | businesswire.comForte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing RulesMay 17 at 2:16 AM | americanbankingnews.comInvestors Buy Large Volume of Call Options on Forte Biosciences (NASDAQ:FBRX)May 13, 2024 | investorplace.comFBRX Stock Earnings: Forte Biosciences Reported Results for Q1 2024May 13, 2024 | businesswire.comForte Biosciences, Inc. Announces First Quarter 2024 Results and Provides Business UpdateApril 10, 2024 | benzinga.comForte Biosciences Stock (NASDAQ:FBRX), Analyst Ratings, Price Targets, PredictionsApril 8, 2024 | markets.businessinsider.comBuy Recommendation for Forte Biosciences on Strong Potential of Novel FB-102 Treatment and Market PositionMarch 19, 2024 | investorplace.comFBRX Stock Earnings: Forte Biosciences Reported Results for Q4 2023March 18, 2024 | businesswire.comForte Biosciences, Inc. Announces 2023 Results and Provides Business UpdateDecember 12, 2023 | morningstar.comForte Biosciences Inc Ordinary SharesDecember 9, 2023 | finance.yahoo.comWe Think Forte Biosciences (NASDAQ:FBRX) Needs To Drive Business Growth CarefullyNovember 15, 2023 | morningstar.comForte Biosciences Inc Ordinary Shares FBRXNovember 14, 2023 | msn.comForte Biosciences GAAP EPS of -$0.26November 13, 2023 | finance.yahoo.comForte Biosciences, Inc. Announces Third Quarter 2023 Results and Provides Business UpdateSeptember 14, 2023 | benzinga.comISS and Glass Lewis Recommend Forte Biosciences Stockholders Vote FOR Boardroom Change at the Company's Upcoming Annual MeetingSeptember 14, 2023 | finance.yahoo.comISS and Glass Lewis Recommend Forte Biosciences Stockholders Vote FOR Boardroom Change at the Company’s Upcoming Annual MeetingSeptember 6, 2023 | finance.yahoo.comConcerned Stockholders of Forte Biosciences and Its Independent Director Candidates Share Key Facts that Reinforce the Need for Urgent Change in the Company’s BoardroomAugust 25, 2023 | businesswire.comConcerned Stockholders of Forte Biosciences File Definitive Proxy Statement and Send Letter to StockholdersAugust 25, 2023 | 247wallst.comCamac Fund Now Owns 4.3% of Forte BiosciencesAugust 14, 2023 | finance.yahoo.comForte Biosciences, Inc. Announces Second Quarter 2023 Results and Provides Business UpdateAugust 3, 2023 | benzinga.comChief Financial Officer At This Health Care Company Buys $149K of StockAugust 1, 2023 | finance.yahoo.comForte Biosciences, Inc. Announces $25 Million Financing and R&D Update for FB-102July 4, 2023 | finance.yahoo.comThis Forte Biosciences Insider Increased Their Holding In The Last YearMay 24, 2023 | finance.yahoo.comWe're Not Very Worried About Forte Biosciences' (NASDAQ:FBRX) Cash Burn RateMay 19, 2023 | finance.yahoo.comForte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing RulesMay 15, 2023 | finance.yahoo.comForte Biosciences, Inc. Announces First Quarter 2023 Results and Provides Business UpdateApril 6, 2023 | msn.comUnusual Call Option Trade in Forte Biosciences (FBRX) Worth $2.50KMarch 31, 2023 | finance.yahoo.comForte Biosciences, Inc. Announces Full Year 2022 Results and Provides Business UpdateJanuary 28, 2023 | seekingalpha.comFBRX Forte Biosciences, Inc.January 25, 2023 | finance.yahoo.comOne Forte Biosciences, Inc. (NASDAQ:FBRX) insider upped their stake by 7.8% in the previous yearJanuary 12, 2023 | finance.yahoo.comMr. David Gryska Appointed to Forte Biosciences Board of DirectorsDecember 15, 2022 | yahoo.comWe Think Forte Biosciences (NASDAQ:FBRX) Can Afford To Drive Business GrowthNovember 15, 2022 | finance.yahoo.comForte Biosciences, Inc. Announces Third Quarter 2022 Results and Provides Business UpdateNovember 15, 2022 | finance.yahoo.comDr. Scott Brun, M.D. Appointed to Forte Biosciences Board of DirectorsOctober 26, 2022 | uk.finance.yahoo.comForte Biosciences, Inc. (FBRX)September 30, 2022 | reuters.comForte Biosciences IncAugust 18, 2022 | stockhouse.comCamac Partners Condemns Forte Biosciences' Seemingly Defensive and Unjustifiable Capital RaiseAugust 17, 2022 | uk.investing.comForte Biosciences Misses Q2 EPS by 4cAugust 17, 2022 | finance.yahoo.comCamac Partners Condemns Forte Biosciences’ Seemingly Defensive and Unjustifiable Capital RaiseAugust 16, 2022 | seekingalpha.comForte Biosciences: Lots Of Clinical Risk Ahead And A Questionable Business PlanJuly 9, 2022 | seekingalpha.comForte Biosciences large shareholders make demands for company's futureJuly 8, 2022 | finance.yahoo.comWe're Keeping An Eye On Forte Biosciences' (NASDAQ:FBRX) Cash Burn RateMay 17, 2022 | seekingalpha.comForte Biosciences GAAP EPS of -$0.17May 16, 2022 | finance.yahoo.comForte Biosciences, Inc. Announces First Quarter 2022 Results and Provides Business UpdateJanuary 12, 2022 | nasdaq.comForte Biosciences Inc Shares Close the Week 21.9% Lower - Weekly WrapDecember 30, 2021 | marketbeat.comStock Traders Buy Large Volume of Call Options on Forte Biosciences (NASDAQ:FBRX)Forte Biosciences, Inc. (NASDAQ:FBRX) was the recipient of some unusual options trading on Wednesday. Stock traders purchased 30,205 call options on the stock. This is an increase of approximately 1,663% compared to the typical daily volume of 1,713 call options.December 15, 2021 | finance.yahoo.comHere's Why We're Watching Forte Biosciences' (NASDAQ:FBRX) Cash Burn SituationSeptember 9, 2021 | apnews.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Forte ...September 9, 2021 | finance.yahoo.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Forte Biosciences, Inc. – FBRXSeptember 8, 2021 | nasdaq.comChief Financial Officer Antony Riley Just Sold A Bunch Of Shares In Forte Biosciences, Inc. (NASDAQ:FBRX) Get Forte Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for FBRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Shocking: One AI startup's revenue could surge 4,735% (Ad)Shocking: One AI Startup's Revenue Could Surge 4,735% While Nvidia gets all the attention, one small AI startup is quietly positioning itself to be the biggest winner. Click here to discover the AI chip company FBRX Media Mentions By Week FBRX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FBRX News Sentiment▼-0.100.42▲Average Medical News Sentiment FBRX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FBRX Articles This Week▼100▲FBRX Articles Average Week Get Forte Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for FBRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ITRM News Today LSTA News Today RNXT News Today ONCT News Today UBX News Today APM News Today TXMD News Today ACST News Today BIOR News Today BFRG News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FBRX) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaShocking: One AI startup's revenue could surge 4,735%Manward Press"The Biggest Drug Ever" Is ComingBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingElon’s New Device is About to Shock the WorldInvestorPlaceMost important medical advance in 100 yearsThe Oxford Club Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Forte Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.